期刊文献+

人脑胶质瘤p53、p15、VEGF的表达及与恶性程度的相关分析 被引量:7

Expressions of p53,p15 and VEGF in human brain glioma and their relationship with malignance degree
下载PDF
导出
摘要 目的研究人脑胶质瘤中p53、p15、血管内皮生长因子(vascular endothelial growth factor,VEGF)的蛋白表达与病理分级的相互关系。方法选取50例不同病理分级的胶质瘤,包括20例Ⅱ级、17例Ⅲ级、13例Ⅳ级,应用免疫组化方法检测其p53、p15和VEGF蛋白表达。结果 p53、VEGF的表达均随胶质瘤病理级别的升高而升高,p15的表达随胶质瘤病理等级的升高而下降。病理分级Ⅱ~Ⅳ级中p53阳性率分别为30%(6/20)、52.9%(9/17)、76.9%(10/13);p15阳性率分别为70%(14/20)、52.9%(9/17)、23.1%(3/13);VEGF阳性率分别为45%(9/20)、70.6%(12/17)、86.7%(12/13)。p53(r=0.374)、p15(r=-0.364)和VEGF(r=0.402)蛋白的表达均与胶质瘤病理分级显著相关(P<0.05)。p53与p15同时阳性表达率18.0%(9/50)、p53与VEGF同时阳性表达率44.0%(22/50)、p15与VEGF同时阳性表达率26%(13/50),p53与p15(r=-0.320)、p53与VEGF(r=0.464)、p15与VEGF(r=-0.352)之间均存在显著相关性(P<0.05)。结论 p53、p15和VEGF蛋白的表达是判断胶质瘤生物学行为的重要指标;其与胶质瘤的发生发展密切相关,且彼此之间相互协同,共同促进肿瘤细胞的增殖与新生血管的生成。 Objective To study the expressions of p53, p15 and vascular endothelial growth factor (VEGF) protein in human brain glioma and their relationship with pathological staging. Methods We chose 50 cases of gliomas of different pathological staging, including 20 cases of Grade Ⅱ glioma, 17 cases of GradeⅢ and 13 cases of Grade IV. Expressions of p53, p15 and VEGF protein were determined by immunohistochemical method. Results Expressions of VEGF and p53 were upregulated while the expression of p15 was downregulated with the increase of glioma pathological grading. In Grade Ⅱ to IV gliomas, the positive rate of p53 was 30%(6/20), 52.9% (9/17) and 76.9%(10/13); that of p15 was 70%(14/20), 52.9%(9/17) and 23.1%(3/13); that of VEGF was 45% (9/20), 70.6%(12/17) and 86.7%(12/13). The expressions of p53 (r=0.374), p15 (r=-0.364) and VEGF (r=0. 402) protein were significantly associated with pathological staging of gliomas (P〈0.05). The positive rate of p53 and p15 was 18.0%(9/50), that of p53 and VEGF was 44.0% (22/50), and that of p15 and VEGF was 26% (13/50). Significant correlation was found between p53 and p15 (r=-0. 320), p53 and VEGF (r =0. 464), and p15 andVEGF (r=-0.352) (P〈0.05). Oonclusion Expressions of p53, p15 and VEGF protein are important indicators for judging the biological behavior of gliomas. They are closely related to the occurrence and development of gliomas, and they synergize one another, jointly promoting the proliferation of tumor cells and the formation of new blood vessels.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期366-370,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 胶质瘤 P53蛋白 P15蛋白 血管内皮生长因子(VEGF) 免疫组化 glioma p53 protein p15 protein vascular endothelial growth factor(VEGF) immunohistochemistry
  • 相关文献

参考文献15

  • 1WESTERMARK B. Glioblastoma--a moving target [J']. Ups J Med Sci, 2012, 117(2) :251-256.
  • 2PAUL K, WEBSTER KC. Pathology and genetics of tumours of the nervous system [M]. New York: Oxford UniversityPress, 1998:121-125.
  • 3LAHAV G, ROSENFELD N, SIGAL A, et al the p53-Mdm2 feedback loop in individual cells [J] 2004, 36(2) :147-150.
  • 4Dynamics of Nat Genet, KORSHUNOV A, GOLANOV A, TIMIRGAZ V. p14ARF protein (FL-132) immunoreactivity in intracranial ependy- momas and its prognostic significance: an analysis of 103 cases [J]. Acta Nenropathol, 2001, 102(3):271-277.
  • 5LI YJ, HOANG-XUAN K, DELATTRE JY, et al. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas [J]. Oncogene, 1995, 11(3) : 597-600.
  • 6GIANI C, FINOCCHIARO G. Mutation rate of the CDKN2 gene in malignant gliomas [J]. Cancer Res, 1994, 54(24): 6338-6339.
  • 7江澄川,胡杰,田新华,吴浩强,彭颂先,唐婉君,陈商群.人脑胶质瘤p16、p15、CDK4基因改变和pRb表达及等位基因谱分析的研究[J].医学研究通讯,2003,32(9):16-17. 被引量:2
  • 8KIL WJ, TOFILON PJ, CAMPHAUSEN K. Post-radiation in- crease in VEGF enhances glioma cell motility in vitro [J]. Ra- diat Oncol, 2012, 7: 25.
  • 9BOGLER O, HUANG HJ, KLEIHUES P, et al. The p53 gene and its role in human brain tumors [J]. Glia, 1995, 15 (3) : 308- 327.
  • 10KIM EL, WI3STENBERG R, ROBSAM A, et al. Chloroquine activates the p53 pathway and induces apoptosis in human glio- ma cells [J]. Neuro Oncol, 2010, 12(4) :389-400.

二级参考文献88

  • 1Lane DP,Crawford LV.T antigen is bound to a host protein in SV40-transformed cells.Nature,1979,278(5701):261-263.
  • 2Linzer DI,Levine AJ.Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.Cell,1979,17(1):43-52.
  • 3Rotter V,Witte ON,Coffman R,Baltimore D.Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein,P50.J Virol,1980,36(2):547-555.
  • 4Levine AJ,Finlay CA,Hinds PW.P53 is a tumor suppressor gene.Cell,2004,116(2 Suppl.):S67-S69.
  • 5Efeyan A,Serrano M.p53:guardian of the genome and policeman of the oncogenes.Cell Cycle,2007,6(9):1006-1010.
  • 6Basse N,Kaar JL,Settanni G,Joerger AC,Rutherford TJ,Fersht AR.Toward the rational design of p53-stabilizing drugs:probing the surface of the oncogenic Y220C mutant.Chem Biol,2010,17(1):46-56.
  • 7Joerger AC,Ang HC,Fersht AR.Structural basis for understanding' oncogenic p53 mutations and designing rescue drugs.Proc Natl Acad Sci USA,2006,103(41):15056-15061.
  • 8Joerger AC,Fersht AR.The tumor suppressor p53:from structures to drug discovery.Cold Spring Harb Perspect Biol,2010,2(6):a000919.
  • 9Kato S,Han SY,Liu W,Otsuka K,Shibata H,Kanamaru R,Ishioka C.Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.Proc Natl Acad Sci USA,2003,100(14):8424-8429.
  • 10Heinlein C,Krepulat F,L(o)hler J,Speidel D,Deppert W,Tolstonog GV.Mutant p53R270H gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.Int J Cancer,2008,122(8):1701-1709.

共引文献23

同被引文献84

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部